Cargando…

Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes?

Introduction: Though the tumour-node-metastasis staging classification is the standard approach to risk stratification in patients with colorectal cancer, several other important variables including the presence of extramural venous invasion (EMVI), the tumour mismatch repair status, as well as surg...

Descripción completa

Detalles Bibliográficos
Autores principales: Conroy, Soraya F, Biddlestone, Leigh R, Courtney, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930915/
https://www.ncbi.nlm.nih.gov/pubmed/36819408
http://dx.doi.org/10.7759/cureus.33832
_version_ 1784889131805966336
author Conroy, Soraya F
Biddlestone, Leigh R
Courtney, Edward
author_facet Conroy, Soraya F
Biddlestone, Leigh R
Courtney, Edward
author_sort Conroy, Soraya F
collection PubMed
description Introduction: Though the tumour-node-metastasis staging classification is the standard approach to risk stratification in patients with colorectal cancer, several other important variables including the presence of extramural venous invasion (EMVI), the tumour mismatch repair status, as well as surgical technique and its influence on lymph node yield all have an impact on long-term survival. This study aims to review both the impact of the type of operation on lymph node yield: complete mesocolic excision (CME) versus right hemicolectomy, and the impact of EMVI and microsatellite instability in predicting overall survival in patients undergoing a right hemicolectomy for colon cancer. Methods: Data of all patients who underwent an elective or emergency right hemicolectomy with curative intent for colon cancer between January 2013 and June 2022 (inclusive) was collected for this single-centre retrospective study. Kaplan-Meier survival curves were calculated using the Statistical Package for the Social Sciences (SPSS version 28, IBM Corp., Armonk, NY) software, and the log-rank (Mantel-Cox) test was used to compare survival distribution between different groups. Results: A total of 421 patients underwent a right hemicolectomy for colon cancer with curative intent during the study period. EMVI was present in 173 (41%) tumours. Survival analysis showed significantly reduced cancer-related survival in patients with EMVI-positive tumours (p < 0.001), with five-year survival rates of 70% in EMVI-positive groups versus 96% in EMVI-negative groups. Subgroup analysis showed a significant difference in survival between node-positive and node-negative tumours in cancers found to have EMVI (p < 0.001). Mean lymph node yield was significantly higher in the CME group versus the standard right hemicolectomy group (p < 0.001). We found no significant difference in survival between patients with microsatellite instability-high (MSI-H) tumours and microsatellite stable (MSS) tumours (p = 0.432). Conclusion: Consideration of tumour biology and adopting the optimum surgical technique are factors that may influence long-term survival in patients with colorectal cancer. Extramural venous invasion is an important prognostic indicator of adverse outcomes in patients with right-sided colon cancer. Our study demonstrates a reduction in survival in patients with EMVI-positive tumours when undertaking subgroup analysis by the presence or absence of nodal disease. Further research needs to be undertaken to compare the relative efficacy of neoadjuvant versus adjuvant chemotherapy in right-sided cancers known to be EMVI-positive as some patients will fail to have adjuvant chemotherapy due to postoperative complications, thereby delaying recovery and missing the optimum window for treatment.
format Online
Article
Text
id pubmed-9930915
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99309152023-02-16 Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes? Conroy, Soraya F Biddlestone, Leigh R Courtney, Edward Cureus Pathology Introduction: Though the tumour-node-metastasis staging classification is the standard approach to risk stratification in patients with colorectal cancer, several other important variables including the presence of extramural venous invasion (EMVI), the tumour mismatch repair status, as well as surgical technique and its influence on lymph node yield all have an impact on long-term survival. This study aims to review both the impact of the type of operation on lymph node yield: complete mesocolic excision (CME) versus right hemicolectomy, and the impact of EMVI and microsatellite instability in predicting overall survival in patients undergoing a right hemicolectomy for colon cancer. Methods: Data of all patients who underwent an elective or emergency right hemicolectomy with curative intent for colon cancer between January 2013 and June 2022 (inclusive) was collected for this single-centre retrospective study. Kaplan-Meier survival curves were calculated using the Statistical Package for the Social Sciences (SPSS version 28, IBM Corp., Armonk, NY) software, and the log-rank (Mantel-Cox) test was used to compare survival distribution between different groups. Results: A total of 421 patients underwent a right hemicolectomy for colon cancer with curative intent during the study period. EMVI was present in 173 (41%) tumours. Survival analysis showed significantly reduced cancer-related survival in patients with EMVI-positive tumours (p < 0.001), with five-year survival rates of 70% in EMVI-positive groups versus 96% in EMVI-negative groups. Subgroup analysis showed a significant difference in survival between node-positive and node-negative tumours in cancers found to have EMVI (p < 0.001). Mean lymph node yield was significantly higher in the CME group versus the standard right hemicolectomy group (p < 0.001). We found no significant difference in survival between patients with microsatellite instability-high (MSI-H) tumours and microsatellite stable (MSS) tumours (p = 0.432). Conclusion: Consideration of tumour biology and adopting the optimum surgical technique are factors that may influence long-term survival in patients with colorectal cancer. Extramural venous invasion is an important prognostic indicator of adverse outcomes in patients with right-sided colon cancer. Our study demonstrates a reduction in survival in patients with EMVI-positive tumours when undertaking subgroup analysis by the presence or absence of nodal disease. Further research needs to be undertaken to compare the relative efficacy of neoadjuvant versus adjuvant chemotherapy in right-sided cancers known to be EMVI-positive as some patients will fail to have adjuvant chemotherapy due to postoperative complications, thereby delaying recovery and missing the optimum window for treatment. Cureus 2023-01-16 /pmc/articles/PMC9930915/ /pubmed/36819408 http://dx.doi.org/10.7759/cureus.33832 Text en Copyright © 2023, Conroy et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pathology
Conroy, Soraya F
Biddlestone, Leigh R
Courtney, Edward
Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes?
title Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes?
title_full Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes?
title_fullStr Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes?
title_full_unstemmed Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes?
title_short Operative and Pathological Factors in Right-Sided Colon Cancers: How Can We Improve the Outcomes?
title_sort operative and pathological factors in right-sided colon cancers: how can we improve the outcomes?
topic Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930915/
https://www.ncbi.nlm.nih.gov/pubmed/36819408
http://dx.doi.org/10.7759/cureus.33832
work_keys_str_mv AT conroysorayaf operativeandpathologicalfactorsinrightsidedcoloncancershowcanweimprovetheoutcomes
AT biddlestoneleighr operativeandpathologicalfactorsinrightsidedcoloncancershowcanweimprovetheoutcomes
AT courtneyedward operativeandpathologicalfactorsinrightsidedcoloncancershowcanweimprovetheoutcomes